{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:38:28Z","timestamp":1783687108558,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI089779"],"award-info":[{"award-number":["AI089779"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI113458"],"award-info":[{"award-number":["AI113458"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jconrel.2017.03.397","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T22:17:17Z","timestamp":1491430637000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination"],"prefix":"10.1016","volume":"255","author":[{"given":"Fan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei X.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.03.397_bb0005","series-title":"Global Tuberculosis Report","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7861\/clinmedicine.14-3-279","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges","volume":"14","author":"G\u00fcnther","year":"2014","journal-title":"Clin. Med."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0015","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1073\/pnas.0600349103","article-title":"Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations","volume":"103","author":"Cohen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0020","first-page":"1481","article-title":"Preventive vaccination against tuberculosis with BCG","volume":"24","author":"Calmette","year":"1931","journal-title":"Proc. R Soc. Med."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tube.2014.10.004","article-title":"The present and future of tuberculosis vaccinations","volume":"95","author":"Principi","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0030","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/cid\/cit793","article-title":"Understanding BCG is the key to improving it","volume":"58","author":"McShane","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0040","doi-asserted-by":"crossref","first-page":"a2052","DOI":"10.1136\/bmj.a2052","article-title":"South African BCG trial team. Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial","volume":"337","author":"Hawkridge","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0045","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1378\/chest.106.5.1463","article-title":"Influence of needle gauge in Mantoux skin testing","volume":"106","author":"Flynn","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/00365540152029981","article-title":"The effects of inadvertent intramuscular injection of BCG vaccine","volume":"33","author":"Pasteur","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0055","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nri1728","article-title":"Immunization without needles","volume":"5","author":"Mitragotri","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0060","first-page":"337","article-title":"Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban","volume":"79","author":"Jeena","year":"2001","journal-title":"S. Afr. Bull. World Health Organ."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0065","first-page":"978","volume":"33","year":"1996","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0070","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.vaccine.2011.01.042","article-title":"Bacillus Calmette-Gu\u00e9rin vaccination using a microneedle patch","volume":"29","author":"Hiraishi","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/10611860600785080","article-title":"Self-dissolving microneedles for the percutaneous absorption of EPO in mice","volume":"14","author":"Ito","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0080","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","article-title":"Dissolving microneedles for transdermal drug delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0085","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/adma.200701205","article-title":"Minimally invasive protein delivery with rapidly dissolving microneedles","volume":"20","author":"Sullivan","year":"2008","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm.2182","article-title":"Dissolving polymer microneedle patches for influenza vaccination","volume":"16","author":"Sullivan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0095","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jconrel.2014.08.006","article-title":"Micro-fractional epidermal powder delivery for improved skin vaccination","volume":"192","author":"Chen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jconrel.2016.05.057","article-title":"Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy","volume":"235","author":"Kumar","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0105","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jconrel.2012.05.030","article-title":"The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin","volume":"161","author":"Liu","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/21645515.2015.1011566","article-title":"Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis","volume":"11","author":"Tirado","year":"2015","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0115","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1016\/j.vaccine.2011.06.077","article-title":"Proteoliposomesfrom Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice","volume":"29","author":"Rodriguez","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tube.2014.10.012","article-title":"BALB\/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL\/6 mice but have equivalent protection","volume":"95","author":"Garcia-Pelayo","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0125","doi-asserted-by":"crossref","first-page":"e21566","DOI":"10.1371\/journal.pone.0021566","article-title":"Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T (EM) cells which expand following virulent mycobacterial challenge","volume":"6","author":"Kaveh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2796.1997.00170.x","article-title":"Hyaluronan: its nature, distribution, functions and turnover","volume":"242","author":"Fraser","year":"1997","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0135","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/ncomms2715","article-title":"A bio-inspired swellable microneedle adhesive for mechanical interlocking with tissue","volume":"4","author":"Yang","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2017.01.030","article-title":"Sustained epidermal powder drug delivery via skin microchannels","volume":"249","author":"Cao","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0145","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1073\/pnas.1500408112","article-title":"Effective and lesion-free cutaneous influenza vaccination","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0155","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/eji.201041180","article-title":"A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2and can aid immune responses to BCG","volume":"41","author":"Evans","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2249.2004.02518.x","article-title":"T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection","volume":"137","author":"Saunders","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-4614-6111-1_12","article-title":"The role of B cells and humoral immunity in Mycobacterium tuberculosis infection","volume":"783","author":"Kozakiewicz","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0170","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: implications for vaccine development","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0175","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1128\/IAI.67.11.5747-5754.1999","article-title":"Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine","volume":"67","author":"Leal","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0180","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.immuni.2009.08.025","article-title":"Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis","volume":"31","author":"Lin","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0185","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.4049\/jimmunol.177.11.7980","article-title":"TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells","volume":"177","author":"Higgins","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0190","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4161\/viru.1.5.12862","article-title":"IL-17 in protective immunity to intracellular pathogens","volume":"1","author":"Khader","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0195","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2012.01.042","article-title":"Microneedle technologies for (trans)dermal drug and vaccine delivery","volume":"161","author":"van der Maaden","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0205","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1109\/JMEMS.2003.820293","article-title":"Silicon micromachined hollow microneedles for transdermal liquid transport","volume":"12","author":"Gardeniers","year":"2003","journal-title":"J. Microelectromech. Syst."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0220","first-page":"1846","article-title":"Novel hollow microneedle technology for depth controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats","volume":"31","author":"van der Maaden","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0235","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2014.04.052","article-title":"Current advances in the fabrication of microneedles for transdermal delivery","volume":"185","author":"Indermun","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0240","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jconrel.2012.04.001","article-title":"Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza","volume":"160","author":"Matsuo","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-8518-6-5","article-title":"An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock","volume":"6","author":"Morefield","year":"2008","journal-title":"J. Immune Based Ther. Vaccines"},{"key":"10.1016\/j.jconrel.2017.03.397_bb0250","first-page":"284","article-title":"NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation","volume":"6","author":"Garc\u00eda-Cuesta","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0255","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2017.03.397_bb0260","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.193.3.271","article-title":"The relative importance of T Cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice","volume":"193","author":"Mogues","year":"2001","journal-title":"J. Exp. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917305102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917305102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T01:51:52Z","timestamp":1601862712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917305102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":47,"alternative-id":["S0168365917305102"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.397","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}